Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I
NCT03071341
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Mucopolysaccharidosis I
Interventions
DRUG:
AGT-181
Sponsor
ArmaGen, Inc